Article Archive
AstraZeneca launches DTP scheme in Poland
17 November 2008
Survey finds disparities in drug access across EU
17 November 2008
Forthcoming meetings and conferences
17 November 2008
Only 52% of Americans plan to get flu shots this year
17 November 2008
$2M profits for spam campaign despite low conversion, says study
17 November 2008
US FDA Review Vouchers criticized
17 November 2008
Folic acid "safe but lacks CV health benefits"
17 November 2008
Retail drug sales in year to September 2008
17 November 2008
Black cohosh linked to lung metastases in mice
17 November 2008
Potentia presents early data from Ph I AMD trial
17 November 2008
GTC facing delisting after NASDAQ warning
17 November 2008
Lack of CV effectiveness for vit E and C in men
17 November 2008
EntreMed achieves endpoint in NSCLC study
17 November 2008
SCS collaborates with CHDI on HD research
17 November 2008
Researchers discover link between gene and cause of blindness
17 November 2008
Celldex in deal with university on Ab development
17 November 2008
StemCells gets $20M equity financing
17 November 2008
Pozen's coated aspirin tablet shows less GI damage
17 November 2008
New EC web site to inform on animal testing alternatives
17 November 2008
OctoPlus enters new CR evaluation accord
17 November 2008
NXL104/ceftazidime enters Ph II cUTI trial
17 November 2008
Biovitrum and Wyeth extend ReFacto supply deal
17 November 2008
Sanofi presents ATHENA trial results at AHA
17 November 2008
Medco study suggests PPIs inhibit B-MS' Plavix
17 November 2008
Bracco licenses 177Lu-AMBA to Marillion
17 November 2008
BI presents long-term Pradaxa data at AHA
17 November 2008
MHRA records 3,451 AE cases with Chantix
17 November 2008
Plethora stock jumps 55% on study results
17 November 2008
S-P UK launches Bridion on local market
17 November 2008
US FDA seizes contaminated heparin
17 November 2008
Medicare Part D changes in California
17 November 2008
GSK/XenoPort withdraw Solzira filing
17 November 2008
Japan stock market week to Nov 10, 2008
17 November 2008
JADO secures 3.9M-euro financing
17 November 2008
deCODE presents AF test data at AHA
17 November 2008
CRN comments on Physician's Health trial
17 November 2008
Sun extends tender offer for Taro
17 November 2008
Penn wins malaria drug contract
17 November 2008
FDA clears Celgene's first placenta-derived stem cell clinical study
17 November 2008
Azur and Elan to co-develop once-daily clozapine
17 November 2008
Critical Pharma raises funds to advance pipeline
17 November 2008
Duska and DSM in manufacturing accord
17 November 2008
TorreyPines sells AD genetics program to Eisai
17 November 2008
Nigeria drug standards improvements wanted
17 November 2008
German OTC drugs "must be reimbursed"
17 November 2008
US FDA seizes contaminated heparin
17 November 2008
deCODE in trouble as cash drained by 3rd qtr
17 November 2008
Richter 3rd-qtr profit up 77% on exchange rates
17 November 2008
Global Fund malaria drug scheme could fail
17 November 2008
BN cost-cuts cannot stop 3rd-qtr profit slipping
17 November 2008
Japan's unsettled drug payments improve
17 November 2008
Teva sales up 20% but Wall Street is cautious
17 November 2008
Japan to survey use of generic drugs
17 November 2008
Canopus gets go-ahead for Ph II trial of HCV drug
17 November 2008
Santhera reports strong animal data on two cachexia drugs
17 November 2008
Solvay launches R3i non-profit organization
17 November 2008
Lilly and Daiichi present heart-attack study
17 November 2008
Japan's NHI list gets 99 generics added
17 November 2008
Wuxi enters three-year ADME analysis accord with Pfizer
17 November 2008
Teva cannot sell generic Prevacid until Nov 2009
17 November 2008
Nanogen links up with Menarini for diagnostics market
17 November 2008
Promising Ph I results with Dendreon's Neuvenge
17 November 2008
Sanofi-Aventis to get Winston product rights for Canada
17 November 2008
Speculation on next FDA Commissioner
17 November 2008
Indian generic firms see US opportunity
17 November 2008
China's govt split over "essential drugs"
17 November 2008
Carbapenems see increased use for hospital in-patients in Europe
17 November 2008
Negative press has compromised Vytorin as first-line therapy; DR
17 November 2008
US PBM receives extortion threat
17 November 2008
Bayer presents results of Xarelto trial at AHA
17 November 2008
PDL out of red ahead of biotech spin-off
17 November 2008
Abbott study data warns about triglycerides
17 November 2008
VIA Pharma presents data from Ph II trial at AHA
17 November 2008
Celadon presents CUPID trial data at AHA
17 November 2008
Ligand falls deeper into loss in 3rd-qtr 2008
17 November 2008
Valeant under estimates but in profit again
17 November 2008
King back to profit after loss of Altace patent
17 November 2008
Dr Reddy's 2nd-qtr fiscal 2009 EPS halves
17 November 2008
UK's RPS publishes azithromycin guidance
17 November 2008
Bavarian Nordic's Ph II Imvamune results to trigger $25M milestone
17 November 2008
Anti-coeliac pill shows promising data
17 November 2008
SYGNIS raises 18.2M euros via capital increase
17 November 2008
Hikma upbeat despite US setback
17 November 2008
DSM has strong 3rd qtr, but drug sales down
17 November 2008
New division Fresenius Kabi reports first results
17 November 2008
Ranbaxy swings to $81.4M loss in 3rd-qtr
17 November 2008
GSK begins trial for new influenza vacc
17 November 2008
BTG presents Varisolve safety trial data at ACP
17 November 2008
Pronova doubles 3rd-qtr profit on Omacor sales
17 November 2008
Salix receives US appro for Apriso in UC
17 November 2008
Toyama's anti-flu drug a "breakthrough"
17 November 2008
Exelixis submits XL413 data package to B-MS
17 November 2008
CV's 3rd-qtr 2008 loss narrows 26% to $25.4M
17 November 2008
Avastin sBLA submitted for glioblastoma
17 November 2008
Expanded US label for CV's angina drug
17 November 2008
Celgene's 3rd-qtr profit triples on drug sales
17 November 2008
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
